Vanguard Group
RAPP

Vanguard Group’s Rapport Therapeutics RAPP Stock Holding History

Vanguard Group’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$55.2M Buy
1,817,757
+191,219
+12% +$5.29M ﹤0.01% 2109
2025
Q3 		$48.3M Buy
1,626,538
+519,047
+47% +$9.26M ﹤0.01% 2174
2025
Q2 		$12.6M Sell
1,107,491
-7,933
-0.7% -$84.2K ﹤0.01% 2786
2025
Q1 		$11.2M Buy
1,115,424
+559,951
+101% +$7.27M ﹤0.01% 2783
2024
Q4 		$9.85M Buy
555,473
+48,706
+10% +$1.08M ﹤0.01% 2969
2024
Q3 		$10.4M Buy
506,767
+436,767
+624% +$9.39M ﹤0.01% 2940
2024
Q2 		$1.63M Buy
+70,000
New +$1.62M ﹤0.01% 3628

Other funds holding RAPP

TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return